• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImmuCell Corporation - Common Stock (NQ:ICCC)

10.29 -0.71 (-6.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ImmuCell Corporation - Common Stock

< Previous 1 2 Next >
News headline image
ImmuCell Q1 Earnings Call Highlights ↗
May 15, 2026
ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever... 
Via MarketBeat
Topics Earnings
News headline image
ImmuCell (ICCC) Q1 2026 Earnings Transcript ↗
May 15, 2026
ImmuCell (ICCC) Q1 2026 Earnings Transcript 
Via The Motley Fool
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell ↗
December 26, 2025
Via Stocktwits
News headline image
Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment
December 24, 2025
In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another... 
Via MarketMinute
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
February 25, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2024 ↗
November 13, 2024
 
Via Benzinga
News headline image
ImmuCell Q2 Profit Jumps as Margins Rise ↗
August 15, 2025
Via The Motley Fool
News headline image
ImmuCell ICCC Q2 2025 Earnings Call Transcript ↗
August 15, 2025
Via The Motley Fool
Topics Earnings
News headline image
ImmuCell Posts 18% Gain in Q2 ↗
August 14, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
June 20, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
May 22, 2025
 
Via Benzinga
News headline image
ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024 ↗
August 13, 2024
ICCC stock results show that ImmuCell beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024 ↗
May 14, 2024
ImmuCell just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 14, 2025
 
Via Benzinga
News headline image
Top Stock Reports For Apple, Eli Lilly & Shopify ↗
February 14, 2025
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co., and Shopify Inc., as well as a micro-cap stock ImmuCell Corp. 
Via Talk Markets
Topics Stocks / Equities
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
February 04, 2025
 
Via Benzinga
News headline image
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday ↗
July 10, 2024
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2024 ↗
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2022 ↗
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2025 ↗
May 14, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
April 09, 2024
 
Via Benzinga
News headline image
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
July 12, 2023
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga
News headline image
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday ↗
July 12, 2023
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
December 14, 2022
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2023 ↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Earnings Scheduled For November 21, 2022 ↗
November 21, 2022
Companies Reporting Before The Bell • Zepp Health (NYSE:ZEPP) is expected to report quarterly earnings at $0.54 per share on revenue of $186.58 million. 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
April 26, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap